Tumour angiogenesis: Hitting cancer where it hurts

Kavitha Sunassee, Richard Vile

Research output: Contribution to journalArticlepeer-review

11 Scopus citations


Two recent studies that involve perturbing tumour blood supply provide new hope for anti-cancer therapies. The first uses elegant molecular engineering to achieve tumour-specific blood clots and the second reports the identification of a natural inhibitor, endostatin, which is produced from tumour extracellular matrix.

Original languageEnglish (US)
Pages (from-to)R282-R285
JournalCurrent Biology
Issue number5
StatePublished - May 1 1997

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)
  • Agricultural and Biological Sciences(all)


Dive into the research topics of 'Tumour angiogenesis: Hitting cancer where it hurts'. Together they form a unique fingerprint.

Cite this